nodes	percent_of_prediction	percent_of_DWPC	metapath
Lurasidone—HTR7—pulmonary artery—dilated cardiomyopathy	0.0427	0.237	CbGeAlD
Lurasidone—HTR7—sympathetic nervous system—dilated cardiomyopathy	0.0416	0.231	CbGeAlD
Lurasidone—HTR2A—pulmonary artery—dilated cardiomyopathy	0.0266	0.148	CbGeAlD
Lurasidone—HTR2A—sympathetic nervous system—dilated cardiomyopathy	0.0259	0.144	CbGeAlD
Lurasidone—Hypersomnia—Lisinopril—dilated cardiomyopathy	0.0234	0.0422	CcSEcCtD
Lurasidone—Breast enlargement—Spironolactone—dilated cardiomyopathy	0.0231	0.0416	CcSEcCtD
Lurasidone—Breast pain—Spironolactone—dilated cardiomyopathy	0.0172	0.0309	CcSEcCtD
Lurasidone—Amenorrhoea—Spironolactone—dilated cardiomyopathy	0.017	0.0307	CcSEcCtD
Lurasidone—Lethargy—Spironolactone—dilated cardiomyopathy	0.0111	0.02	CcSEcCtD
Lurasidone—Serum creatinine increased—Lisinopril—dilated cardiomyopathy	0.00993	0.0179	CcSEcCtD
Lurasidone—Gastritis—Spironolactone—dilated cardiomyopathy	0.00962	0.0173	CcSEcCtD
Lurasidone—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.0093	0.0168	CcSEcCtD
Lurasidone—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.00865	0.0156	CcSEcCtD
Lurasidone—Renal failure—Spironolactone—dilated cardiomyopathy	0.00823	0.0148	CcSEcCtD
Lurasidone—ADRA2C—cardiac ventricle—dilated cardiomyopathy	0.00817	0.0454	CbGeAlD
Lurasidone—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.00781	0.0141	CcSEcCtD
Lurasidone—ADRA2C—myocardium—dilated cardiomyopathy	0.00768	0.0427	CbGeAlD
Lurasidone—Breast pain—Lisinopril—dilated cardiomyopathy	0.007	0.0126	CcSEcCtD
Lurasidone—Diabetes mellitus—Furosemide—dilated cardiomyopathy	0.0068	0.0123	CcSEcCtD
Lurasidone—Creatinine increased—Lisinopril—dilated cardiomyopathy	0.00642	0.0116	CcSEcCtD
Lurasidone—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00629	0.0113	CcSEcCtD
Lurasidone—Neck pain—Lisinopril—dilated cardiomyopathy	0.00618	0.0112	CcSEcCtD
Lurasidone—Pulmonary embolism—Lisinopril—dilated cardiomyopathy	0.00611	0.011	CcSEcCtD
Lurasidone—Lethargy—Furosemide—dilated cardiomyopathy	0.00603	0.0109	CcSEcCtD
Lurasidone—Salivary hypersecretion—Lisinopril—dilated cardiomyopathy	0.00593	0.0107	CcSEcCtD
Lurasidone—Malaise—Spironolactone—dilated cardiomyopathy	0.0059	0.0106	CcSEcCtD
Lurasidone—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00586	0.0106	CcSEcCtD
Lurasidone—HTR7—heart—dilated cardiomyopathy	0.00583	0.0324	CbGeAlD
Lurasidone—Blood creatinine increased—Furosemide—dilated cardiomyopathy	0.00554	0.00999	CcSEcCtD
Lurasidone—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.0054	0.00974	CcSEcCtD
Lurasidone—ADRA2C—heart—dilated cardiomyopathy	0.00536	0.0298	CbGeAlD
Lurasidone—Sleep disorder—Lisinopril—dilated cardiomyopathy	0.00512	0.00924	CcSEcCtD
Lurasidone—Diabetes mellitus—Lisinopril—dilated cardiomyopathy	0.0051	0.0092	CcSEcCtD
Lurasidone—Eosinophilia—Furosemide—dilated cardiomyopathy	0.00506	0.00912	CcSEcCtD
Lurasidone—Somnolence—Spironolactone—dilated cardiomyopathy	0.00475	0.00856	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00461	0.00832	CcSEcCtD
Lurasidone—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.00461	0.00831	CcSEcCtD
Lurasidone—ADRA2C—cardiac atrium—dilated cardiomyopathy	0.00459	0.0255	CbGeAlD
Lurasidone—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.00453	0.00816	CcSEcCtD
Lurasidone—Renal failure—Furosemide—dilated cardiomyopathy	0.00448	0.00808	CcSEcCtD
Lurasidone—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.00444	0.008	CcSEcCtD
Lurasidone—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.00431	0.00777	CcSEcCtD
Lurasidone—ADRA2A—heart—dilated cardiomyopathy	0.00428	0.0238	CbGeAlD
Lurasidone—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00425	0.00767	CcSEcCtD
Lurasidone—Blood creatinine increased—Lisinopril—dilated cardiomyopathy	0.00416	0.00749	CcSEcCtD
Lurasidone—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.00405	0.00731	CcSEcCtD
Lurasidone—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.00404	0.00728	CcSEcCtD
Lurasidone—Urethral disorder—Furosemide—dilated cardiomyopathy	0.00401	0.00723	CcSEcCtD
Lurasidone—Breast disorder—Lisinopril—dilated cardiomyopathy	0.00401	0.00723	CcSEcCtD
Lurasidone—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.00397	0.00715	CcSEcCtD
Lurasidone—Gastritis—Lisinopril—dilated cardiomyopathy	0.00393	0.00708	CcSEcCtD
Lurasidone—Influenza—Lisinopril—dilated cardiomyopathy	0.00383	0.00691	CcSEcCtD
Lurasidone—Eye disorder—Furosemide—dilated cardiomyopathy	0.00382	0.00689	CcSEcCtD
Lurasidone—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.0038	0.00685	CcSEcCtD
Lurasidone—Pruritus—Spironolactone—dilated cardiomyopathy	0.00378	0.00681	CcSEcCtD
Lurasidone—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.00373	0.00673	CcSEcCtD
Lurasidone—Angiopathy—Furosemide—dilated cardiomyopathy	0.00371	0.00669	CcSEcCtD
Lurasidone—ADRA2A—cardiac atrium—dilated cardiomyopathy	0.00366	0.0203	CbGeAlD
Lurasidone—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00365	0.00659	CcSEcCtD
Lurasidone—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00365	0.00659	CcSEcCtD
Lurasidone—HTR2A—heart—dilated cardiomyopathy	0.00364	0.0202	CbGeAlD
Lurasidone—Dysuria—Lisinopril—dilated cardiomyopathy	0.00358	0.00646	CcSEcCtD
Lurasidone—Neutropenia—Lisinopril—dilated cardiomyopathy	0.00358	0.00646	CcSEcCtD
Lurasidone—Malnutrition—Furosemide—dilated cardiomyopathy	0.00356	0.00642	CcSEcCtD
Lurasidone—Dizziness—Spironolactone—dilated cardiomyopathy	0.00353	0.00637	CcSEcCtD
Lurasidone—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.00353	0.00637	CcSEcCtD
Lurasidone—Flatulence—Furosemide—dilated cardiomyopathy	0.00351	0.00633	CcSEcCtD
Lurasidone—Weight increased—Lisinopril—dilated cardiomyopathy	0.00349	0.00629	CcSEcCtD
Lurasidone—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.00346	0.00624	CcSEcCtD
Lurasidone—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00342	0.00617	CcSEcCtD
Lurasidone—Vomiting—Spironolactone—dilated cardiomyopathy	0.0034	0.00612	CcSEcCtD
Lurasidone—Rash—Spironolactone—dilated cardiomyopathy	0.00337	0.00607	CcSEcCtD
Lurasidone—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00336	0.00607	CcSEcCtD
Lurasidone—Renal failure—Lisinopril—dilated cardiomyopathy	0.00336	0.00606	CcSEcCtD
Lurasidone—Vision blurred—Furosemide—dilated cardiomyopathy	0.00335	0.00605	CcSEcCtD
Lurasidone—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.00332	0.00599	CcSEcCtD
Lurasidone—Anaemia—Furosemide—dilated cardiomyopathy	0.00329	0.00593	CcSEcCtD
Lurasidone—Agitation—Furosemide—dilated cardiomyopathy	0.00327	0.0059	CcSEcCtD
Lurasidone—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.00323	0.00583	CcSEcCtD
Lurasidone—Vertigo—Furosemide—dilated cardiomyopathy	0.0032	0.00577	CcSEcCtD
Lurasidone—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.00319	0.00575	CcSEcCtD
Lurasidone—Leukopenia—Furosemide—dilated cardiomyopathy	0.00319	0.00575	CcSEcCtD
Lurasidone—Nausea—Spironolactone—dilated cardiomyopathy	0.00317	0.00572	CcSEcCtD
Lurasidone—Bradycardia—Lisinopril—dilated cardiomyopathy	0.00312	0.00563	CcSEcCtD
Lurasidone—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.00303	0.00547	CcSEcCtD
Lurasidone—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.00301	0.00543	CcSEcCtD
Lurasidone—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.00301	0.00542	CcSEcCtD
Lurasidone—Dry mouth—Furosemide—dilated cardiomyopathy	0.00296	0.00535	CcSEcCtD
Lurasidone—Shock—Furosemide—dilated cardiomyopathy	0.00286	0.00516	CcSEcCtD
Lurasidone—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00285	0.00514	CcSEcCtD
Lurasidone—Skin disorder—Furosemide—dilated cardiomyopathy	0.00282	0.00509	CcSEcCtD
Lurasidone—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00281	0.00507	CcSEcCtD
Lurasidone—Angiopathy—Lisinopril—dilated cardiomyopathy	0.00278	0.00502	CcSEcCtD
Lurasidone—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.00274	0.00494	CcSEcCtD
Lurasidone—Hypotension—Furosemide—dilated cardiomyopathy	0.00271	0.0049	CcSEcCtD
Lurasidone—Mental disorder—Lisinopril—dilated cardiomyopathy	0.00269	0.00485	CcSEcCtD
Lurasidone—Malnutrition—Lisinopril—dilated cardiomyopathy	0.00267	0.00482	CcSEcCtD
Lurasidone—Flatulence—Lisinopril—dilated cardiomyopathy	0.00263	0.00475	CcSEcCtD
Lurasidone—Back pain—Lisinopril—dilated cardiomyopathy	0.00258	0.00466	CcSEcCtD
Lurasidone—Somnolence—Furosemide—dilated cardiomyopathy	0.00258	0.00466	CcSEcCtD
Lurasidone—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.00257	0.00463	CcSEcCtD
Lurasidone—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00253	0.00456	CcSEcCtD
Lurasidone—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00252	0.00454	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00251	0.00452	CcSEcCtD
Lurasidone—Fatigue—Furosemide—dilated cardiomyopathy	0.0025	0.00452	CcSEcCtD
Lurasidone—Tremor—Lisinopril—dilated cardiomyopathy	0.0025	0.00451	CcSEcCtD
Lurasidone—Anaemia—Lisinopril—dilated cardiomyopathy	0.00247	0.00445	CcSEcCtD
Lurasidone—Angioedema—Lisinopril—dilated cardiomyopathy	0.00244	0.0044	CcSEcCtD
Lurasidone—Malaise—Lisinopril—dilated cardiomyopathy	0.00241	0.00434	CcSEcCtD
Lurasidone—Vertigo—Lisinopril—dilated cardiomyopathy	0.0024	0.00433	CcSEcCtD
Lurasidone—Syncope—Lisinopril—dilated cardiomyopathy	0.0024	0.00432	CcSEcCtD
Lurasidone—Leukopenia—Lisinopril—dilated cardiomyopathy	0.00239	0.00431	CcSEcCtD
Lurasidone—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00238	0.00428	CcSEcCtD
Lurasidone—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00235	0.00423	CcSEcCtD
Lurasidone—Abdominal pain—Furosemide—dilated cardiomyopathy	0.0023	0.00414	CcSEcCtD
Lurasidone—Myalgia—Lisinopril—dilated cardiomyopathy	0.00227	0.0041	CcSEcCtD
Lurasidone—Anxiety—Lisinopril—dilated cardiomyopathy	0.00227	0.00409	CcSEcCtD
Lurasidone—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.00226	0.00407	CcSEcCtD
Lurasidone—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00222	0.00401	CcSEcCtD
Lurasidone—Infection—Lisinopril—dilated cardiomyopathy	0.00217	0.00391	CcSEcCtD
Lurasidone—Shock—Lisinopril—dilated cardiomyopathy	0.00214	0.00387	CcSEcCtD
Lurasidone—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00213	0.00384	CcSEcCtD
Lurasidone—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00212	0.00382	CcSEcCtD
Lurasidone—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00211	0.0038	CcSEcCtD
Lurasidone—Asthenia—Furosemide—dilated cardiomyopathy	0.00208	0.00376	CcSEcCtD
Lurasidone—Pruritus—Furosemide—dilated cardiomyopathy	0.00206	0.00371	CcSEcCtD
Lurasidone—Hypotension—Lisinopril—dilated cardiomyopathy	0.00204	0.00367	CcSEcCtD
Lurasidone—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00199	0.00359	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00199	0.00358	CcSEcCtD
Lurasidone—Insomnia—Lisinopril—dilated cardiomyopathy	0.00197	0.00356	CcSEcCtD
Lurasidone—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00194	0.00351	CcSEcCtD
Lurasidone—Somnolence—Lisinopril—dilated cardiomyopathy	0.00194	0.0035	CcSEcCtD
Lurasidone—Dizziness—Furosemide—dilated cardiomyopathy	0.00192	0.00347	CcSEcCtD
Lurasidone—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00192	0.00346	CcSEcCtD
Lurasidone—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00189	0.00342	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00188	0.00339	CcSEcCtD
Lurasidone—Fatigue—Lisinopril—dilated cardiomyopathy	0.00188	0.00339	CcSEcCtD
Lurasidone—Vomiting—Furosemide—dilated cardiomyopathy	0.00185	0.00333	CcSEcCtD
Lurasidone—Rash—Furosemide—dilated cardiomyopathy	0.00183	0.0033	CcSEcCtD
Lurasidone—Dermatitis—Furosemide—dilated cardiomyopathy	0.00183	0.0033	CcSEcCtD
Lurasidone—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00178	0.00321	CcSEcCtD
Lurasidone—Nausea—Furosemide—dilated cardiomyopathy	0.00173	0.00311	CcSEcCtD
Lurasidone—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00172	0.00311	CcSEcCtD
Lurasidone—Asthenia—Lisinopril—dilated cardiomyopathy	0.00156	0.00282	CcSEcCtD
Lurasidone—Pruritus—Lisinopril—dilated cardiomyopathy	0.00154	0.00278	CcSEcCtD
Lurasidone—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00149	0.00269	CcSEcCtD
Lurasidone—Dizziness—Lisinopril—dilated cardiomyopathy	0.00144	0.0026	CcSEcCtD
Lurasidone—Vomiting—Lisinopril—dilated cardiomyopathy	0.00139	0.0025	CcSEcCtD
Lurasidone—Rash—Lisinopril—dilated cardiomyopathy	0.00137	0.00248	CcSEcCtD
Lurasidone—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00137	0.00248	CcSEcCtD
Lurasidone—Nausea—Lisinopril—dilated cardiomyopathy	0.00129	0.00234	CcSEcCtD
Lurasidone—HTR2A—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000431	0.00163	CbGpPWpGaD
Lurasidone—HTR2A—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000431	0.00163	CbGpPWpGaD
Lurasidone—DRD2—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00042	0.00158	CbGpPWpGaD
Lurasidone—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.000414	0.00156	CbGpPWpGaD
Lurasidone—HTR2A—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000413	0.00156	CbGpPWpGaD
Lurasidone—ADRA2A—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	0.000409	0.00154	CbGpPWpGaD
Lurasidone—DRD2—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000408	0.00154	CbGpPWpGaD
Lurasidone—HTR2A—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000401	0.00151	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—SDHA—dilated cardiomyopathy	0.000398	0.0015	CbGpPWpGaD
Lurasidone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000396	0.00149	CbGpPWpGaD
Lurasidone—DRD2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000395	0.00149	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000393	0.00148	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000393	0.00148	CbGpPWpGaD
Lurasidone—DRD2—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000392	0.00148	CbGpPWpGaD
Lurasidone—HTR2A—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000389	0.00146	CbGpPWpGaD
Lurasidone—ADRA2A—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	0.000386	0.00145	CbGpPWpGaD
Lurasidone—HTR1A—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000384	0.00145	CbGpPWpGaD
Lurasidone—HTR7—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000381	0.00143	CbGpPWpGaD
Lurasidone—HTR7—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000381	0.00143	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—ANKRD1—dilated cardiomyopathy	0.00038	0.00143	CbGpPWpGaD
Lurasidone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000376	0.00142	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000372	0.0014	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000365	0.00137	CbGpPWpGaD
Lurasidone—HTR7—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000365	0.00137	CbGpPWpGaD
Lurasidone—HTR1A—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000364	0.00137	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—TAZ—dilated cardiomyopathy	0.000358	0.00135	CbGpPWpGaD
Lurasidone—HTR1A—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000355	0.00134	CbGpPWpGaD
Lurasidone—HTR7—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000354	0.00133	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000353	0.00133	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000353	0.00133	CbGpPWpGaD
Lurasidone—ADRA2A—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000351	0.00132	CbGpPWpGaD
Lurasidone—HTR7—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000346	0.0013	CbGpPWpGaD
Lurasidone—HTR7—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000346	0.0013	CbGpPWpGaD
Lurasidone—ADRA2C—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000343	0.00129	CbGpPWpGaD
Lurasidone—HTR7—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000343	0.00129	CbGpPWpGaD
Lurasidone—DRD2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000337	0.00127	CbGpPWpGaD
Lurasidone—HTR2A—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000332	0.00125	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—SDHA—dilated cardiomyopathy	0.000323	0.00122	CbGpPWpGaD
Lurasidone—HTR7—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000322	0.00121	CbGpPWpGaD
Lurasidone—DRD2—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00032	0.0012	CbGpPWpGaD
Lurasidone—ADRA2C—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	0.000315	0.00119	CbGpPWpGaD
Lurasidone—HTR2A—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000315	0.00119	CbGpPWpGaD
Lurasidone—DRD2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000312	0.00117	CbGpPWpGaD
Lurasidone—HTR7—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000311	0.00117	CbGpPWpGaD
Lurasidone—HTR2A—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000307	0.00115	CbGpPWpGaD
Lurasidone—ADRA2C—Hemostasis—ITGB1—dilated cardiomyopathy	0.000304	0.00115	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000302	0.00114	CbGpPWpGaD
Lurasidone—HTR7—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000293	0.0011	CbGpPWpGaD
Lurasidone—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000287	0.00108	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000286	0.00108	CbGpPWpGaD
Lurasidone—HTR1A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000282	0.00106	CbGpPWpGaD
Lurasidone—HTR1A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000282	0.00106	CbGpPWpGaD
Lurasidone—HTR1A—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000281	0.00106	CbGpPWpGaD
Lurasidone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000279	0.00105	CbGpPWpGaD
Lurasidone—HTR7—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000278	0.00105	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000273	0.00103	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000273	0.00103	CbGpPWpGaD
Lurasidone—HTR1A—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00027	0.00102	CbGpPWpGaD
Lurasidone—HTR7—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000266	0.001	CbGpPWpGaD
Lurasidone—HTR1A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000262	0.000988	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000262	0.000985	CbGpPWpGaD
Lurasidone—ADRA2C—Hemostasis—CD36—dilated cardiomyopathy	0.00026	0.000978	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000256	0.000965	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000256	0.000965	CbGpPWpGaD
Lurasidone—ADRA2A—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	0.000256	0.000963	CbGpPWpGaD
Lurasidone—HTR1A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000254	0.000957	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000254	0.000956	CbGpPWpGaD
Lurasidone—HTR7—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000252	0.00095	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000248	0.000934	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000248	0.000934	CbGpPWpGaD
Lurasidone—DRD2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000248	0.000933	CbGpPWpGaD
Lurasidone—DRD2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000248	0.000933	CbGpPWpGaD
Lurasidone—ADRA2A—Hemostasis—ITGB1—dilated cardiomyopathy	0.000247	0.000932	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000246	0.000926	CbGpPWpGaD
Lurasidone—ADRA2C—Hemostasis—RAC1—dilated cardiomyopathy	0.000245	0.000922	CbGpPWpGaD
Lurasidone—HTR2A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000244	0.000918	CbGpPWpGaD
Lurasidone—HTR2A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000244	0.000918	CbGpPWpGaD
Lurasidone—HTR2A—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000243	0.000914	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000238	0.000898	CbGpPWpGaD
Lurasidone—DRD2—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000237	0.000894	CbGpPWpGaD
Lurasidone—HTR2A—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000233	0.000879	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000231	0.000869	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000231	0.000868	CbGpPWpGaD
Lurasidone—DRD2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.00023	0.000868	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.00023	0.000867	CbGpPWpGaD
Lurasidone—HTR2A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000227	0.000854	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000225	0.000848	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000225	0.000848	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000223	0.000841	CbGpPWpGaD
Lurasidone—DRD2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000223	0.00084	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000222	0.000836	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000222	0.000836	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000221	0.000834	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000221	0.000834	CbGpPWpGaD
Lurasidone—HTR2A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00022	0.000827	CbGpPWpGaD
Lurasidone—HTR1A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000217	0.000817	CbGpPWpGaD
Lurasidone—HTR7—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000216	0.000812	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000212	0.0008	CbGpPWpGaD
Lurasidone—ADRA2A—Hemostasis—CD36—dilated cardiomyopathy	0.000211	0.000795	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.00021	0.000791	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000209	0.000788	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000206	0.000777	CbGpPWpGaD
Lurasidone—HTR7—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000206	0.000776	CbGpPWpGaD
Lurasidone—HTR1A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000206	0.000776	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000206	0.000775	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000204	0.00077	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000204	0.00077	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000203	0.000763	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000201	0.000759	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000201	0.000759	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.0002	0.000752	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000199	0.000751	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000199	0.00075	CbGpPWpGaD
Lurasidone—ADRA2A—Hemostasis—RAC1—dilated cardiomyopathy	0.000199	0.000749	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000197	0.000742	CbGpPWpGaD
Lurasidone—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000197	0.000742	CbGpPWpGaD
Lurasidone—HTR7—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000196	0.000738	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000191	0.000718	CbGpPWpGaD
Lurasidone—DRD2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000191	0.000718	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.00019	0.000715	CbGpPWpGaD
Lurasidone—HTR2A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000188	0.000706	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000187	0.000705	CbGpPWpGaD
Lurasidone—HTR7—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000187	0.000705	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000187	0.000704	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000184	0.000693	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000181	0.000683	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000181	0.000681	CbGpPWpGaD
Lurasidone—DRD2—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000181	0.000681	CbGpPWpGaD
Lurasidone—HTR2A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000178	0.00067	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000173	0.000652	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000171	0.000643	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000171	0.000642	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.00017	0.000641	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000165	0.000622	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000164	0.000618	CbGpPWpGaD
Lurasidone—ADRA2C—Hemostasis—RAF1—dilated cardiomyopathy	0.000162	0.000611	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	0.000162	0.00061	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000162	0.00061	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000162	0.000608	CbGpPWpGaD
Lurasidone—HTR1A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.00016	0.000602	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000157	0.000592	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000155	0.000583	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000155	0.000583	CbGpPWpGaD
Lurasidone—HTR1A—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000153	0.000575	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	0.000152	0.000574	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000151	0.00057	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000151	0.00057	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.00015	0.000564	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000149	0.000561	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000148	0.000557	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000147	0.000555	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000147	0.000554	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000147	0.000552	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000147	0.000552	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000145	0.000547	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000141	0.00053	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.00014	0.000529	CbGpPWpGaD
Lurasidone—DRD2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.00014	0.000529	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000139	0.000522	CbGpPWpGaD
Lurasidone—HTR2A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000138	0.00052	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	0.000138	0.000519	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000136	0.000513	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000136	0.000513	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000134	0.000505	CbGpPWpGaD
Lurasidone—DRD2—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000134	0.000505	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000134	0.000505	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000133	0.000501	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000133	0.000501	CbGpPWpGaD
Lurasidone—HTR2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000132	0.000497	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000132	0.000497	CbGpPWpGaD
Lurasidone—ADRA2A—Hemostasis—RAF1—dilated cardiomyopathy	0.000132	0.000497	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000131	0.000493	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000131	0.000493	CbGpPWpGaD
Lurasidone—HTR7—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.00013	0.000489	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000128	0.000482	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000127	0.00048	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000126	0.000473	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000125	0.000472	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000124	0.000466	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000122	0.000459	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000122	0.000458	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.00012	0.000452	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—AGT—dilated cardiomyopathy	0.00012	0.000451	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.00012	0.000451	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000119	0.000448	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000119	0.000448	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000118	0.000444	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000116	0.000439	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000116	0.000436	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000114	0.00043	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000113	0.000424	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000111	0.000417	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—AGT—dilated cardiomyopathy	0.000111	0.000416	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.00011	0.000416	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000109	0.000411	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—GPX1—dilated cardiomyopathy	0.000108	0.000407	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000107	0.000404	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000107	0.000403	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—CD36—dilated cardiomyopathy	0.000105	0.000397	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000102	0.000385	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000101	0.000379	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—ADRB2—dilated cardiomyopathy	9.7e-05	0.000365	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	9.63e-05	0.000363	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	9.54e-05	0.000359	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	9.49e-05	0.000357	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—AGT—dilated cardiomyopathy	9.48e-05	0.000357	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—RAF1—dilated cardiomyopathy	9.31e-05	0.000351	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	9.18e-05	0.000346	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	9.15e-05	0.000345	CbGpPWpGaD
Lurasidone—HTR7—Signaling by GPCR—EGFR—dilated cardiomyopathy	8.91e-05	0.000335	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—GPX1—dilated cardiomyopathy	8.78e-05	0.000331	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	8.68e-05	0.000327	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—RAC1—dilated cardiomyopathy	8.58e-05	0.000323	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—CD36—dilated cardiomyopathy	8.55e-05	0.000322	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—RAF1—dilated cardiomyopathy	8.45e-05	0.000318	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	8.33e-05	0.000314	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	8.32e-05	0.000313	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—RAC1—dilated cardiomyopathy	8.3e-05	0.000313	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	8.2e-05	0.000309	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—AGT—dilated cardiomyopathy	8.19e-05	0.000309	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—AGT—dilated cardiomyopathy	7.93e-05	0.000299	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—AGT—dilated cardiomyopathy	7.7e-05	0.00029	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—RAF1—dilated cardiomyopathy	7.67e-05	0.000289	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	7.57e-05	0.000285	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—RAC1—dilated cardiomyopathy	7.53e-05	0.000284	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	7.46e-05	0.000281	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—RAC1—dilated cardiomyopathy	7.41e-05	0.000279	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—AGT—dilated cardiomyopathy	7.19e-05	0.000271	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—AGT—dilated cardiomyopathy	7.08e-05	0.000267	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—RAC1—dilated cardiomyopathy	6.74e-05	0.000254	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	6.6e-05	0.000249	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—AGT—dilated cardiomyopathy	6.44e-05	0.000243	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—EGFR—dilated cardiomyopathy	6.39e-05	0.000241	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—EGFR—dilated cardiomyopathy	5.8e-05	0.000218	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	5.7e-05	0.000215	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—RAF1—dilated cardiomyopathy	5.69e-05	0.000214	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—RAF1—dilated cardiomyopathy	5.5e-05	0.000207	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—EGFR—dilated cardiomyopathy	5.26e-05	0.000198	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	5.19e-05	0.000195	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—RAF1—dilated cardiomyopathy	4.99e-05	0.000188	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—RAF1—dilated cardiomyopathy	4.91e-05	0.000185	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—RAF1—dilated cardiomyopathy	4.47e-05	0.000168	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—EGFR—dilated cardiomyopathy	3.9e-05	0.000147	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—EGFR—dilated cardiomyopathy	3.77e-05	0.000142	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	3.74e-05	0.000141	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	3.64e-05	0.000137	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—EGFR—dilated cardiomyopathy	3.42e-05	0.000129	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—EGFR—dilated cardiomyopathy	3.37e-05	0.000127	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	3.28e-05	0.000124	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—EGFR—dilated cardiomyopathy	3.06e-05	0.000115	CbGpPWpGaD
